TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07636785: A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Sponsor: VM Discovery, Inc. · Phase: PHASE1/PHASE2 · Area: ONCOLOGY · Target Enrollment: 111 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$12,566,400

Rescue Site Savings

+$8,285,970

Unlock Full NCT07636785 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07636785 Rescue Dossier →